A digital tool for assessing cognitive impairment in stroke survivors
Understanding Factors Affecting Cognitive Function in Cerebrovascular Disease
This study is testing a new digital tool that helps stroke survivors check for thinking and memory problems on their own to improve their care after a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Imperial College London Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT05885295 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and validate the Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3), a self-administered digital tool designed to detect cognitive impairments in patients who have experienced a stroke. The IC3 will assess both general and specific cognitive deficits, allowing for scalable and cost-effective monitoring independent of trained professionals. The study will also explore the relationship between cognitive outcomes and various biomarkers, including MRI imaging and blood tests, over the first year following a stroke. By providing a comprehensive and standardized approach to cognitive assessment, the IC3 seeks to improve post-stroke care and monitoring.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 who have experienced a confirmed stroke and can engage in cognitive testing.
Not a fit: Patients with a pre-stroke diagnosis of dementia or severe cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly enhance the ability to identify and monitor cognitive deficits in stroke survivors, leading to better tailored rehabilitation strategies.
How similar studies have performed: While cognitive assessments post-stroke are common, the IC3 represents a novel approach that has not been extensively tested in this specific context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged \> 18 * Evidence of confirmed stroke (for patients) * Ability to concentrate for 15 minutes at a time to engage with cognitive testing Exclusion Criteria for the main study: * Pre-stroke diagnosis of dementia * Severe visuo-spatial problems, fatigue, or mental health problems * Severe hearing impairment in the presence of reading comprehension impairment Exclusion Criteria for the MRI imaging sub-study: * Pregnancy * Presence of metal implants * Claustrophobia
Where this trial is running
London
- Imperial College London — London, United Kingdom (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.